• Info
  • Insider Ownership

Insider Trading & Ownership of Karen L. Smith

Location
Dublin L2 4, Ireland
Summary
The estimated net worth of Karen L. Smith is at least $461,924 dollars as of 16 Jun 2025. Karen L. Smith is the Director of Aurinia Pharmaceuticals Inc. and owns shares of Aurinia Pharmaceuticals Inc. (AUPH) stock worth about $209.1K. Karen L. Smith is the Chief Medical Officer of Quince Therapeutics, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $183K. Karen L. Smith is the Director of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $47K. Karen L. Smith is the EVP, Chief Medical Officer of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $21.6K. Karen L. Smith is the Director of Skye Bioscience, Inc. and owns shares of Skye Bioscience, Inc. (SKYE) stock worth about $1.2K.
Signature
/s/ Prathyusha Duraibabu, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Karen L. Smith files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Karen L. Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AUPH Aurinia Pharmaceuticals Inc. Director $209,123 21 Nov 2024
QNCX Quince Therapeutics, Inc. Chief Medical Officer $183,009 01 Feb 2023
SGMO SANGAMO THERAPEUTICS, INC Director $46,966 12 Jun 2025
EBS Emergent BioSolutions Inc. EVP, Chief Medical Officer $21,636 07 May 2021
SKYE Skye Bioscience, Inc. Director $1,190 24 Feb 2025
XLRN ACCELERON PHARMA INC Director 19 Nov 2021
ATRS ANTARES PHARMA, INC. Director 24 May 2022
CNTX Context Therapeutics Inc. Director 12 Jun 2025
TRML Talaris Therapeutics, Inc. Director 13 Jun 2023

Insider Transactions Reported by Karen L. Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.